首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of headache and pain

缩写:J HEADACHE PAIN

ISSN:1129-2369

e-ISSN:1129-2377

IF/分区:7.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2404
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Raffaele Ornello,Carlo Baraldi,Simona Guerzoni et al. Raffaele Ornello et al.
Background: Monoclonal antibodies acting on the calcitonin gene-related peptide (CGRP) or its receptor have changed migraine preventive treatment. Those treatments have led to reconsidering the outcomes of migraine preven...
Katharina Kamm,Andreas Straube,Ruth Ruscheweyh Katharina Kamm
Background: Cluster headache (CH) is a severe, highly disabling primary headache disorder. However, there is little research on CH-related disability, and most of it is based on non CH-specific questionnaires. The aim of ...
Doga Vuralli,Burak Arslan,Elif Topa et al. Doga Vuralli et al.
Background/aim: Certain constituents in migraine food triggers and non-steroidal anti-inflammatory drugs (NSAIDs) inhibit sulfotransferases (SULTs) that detoxify drugs/chemicals and play role in the metabolism of neurotra...
Ruimin Tian,Yun Zhang,Qi Pan et al. Ruimin Tian et al.
Background: Vestibular symptoms are frequently reported in patients with chronic migraine (CM). However, whether vestibular symptoms arise through overlapping neurobiology of migraine remains to be elucidated. The neurope...
Raquel Gil-Gouveia Raquel Gil-Gouveia
The paper from Steiner et al. suggests that an outcome measure expressed in time units may be an adequate method to assess the impact of headache disorders, regardless of diagnosis or health care setting, proving useful for cost-benefit ana...
Dawn C Buse,Paul K Winner,Larry Charleston th et al. Dawn C Buse et al.
Background: A clinical ability to describe the response trajectory of patients receiving preventive migraine treatment could expedite and improve therapeutic management decisions. This post hoc analysis of the PROMISE-2 s...
Isabella Mai Christiansen,Jacob C A Edvinsson,Philip V Reducha et al. Isabella Mai Christiansen et al.
Background: Based on the current understanding of the role of neuropeptide signalling in migraine, we explored the therapeutic potential of a specific cannabinoid agonist. The aim of the present study was to examine the e...
Yu-Chen Cheng,Bing-Yan Zeng,Chao-Ming Hung et al. Yu-Chen Cheng et al.
Background: Current pharmacologic prophylactic strategies for migraine have exhibited limited efficacy, with response rates as low as 40%-50%. In addition to the limited efficacy, the acceptability of those pharmacologic ...